| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biochemistry and Biophysics |
Departments of Ecology, Evolution, and Marine Biology [H. M., R. S. J.] and Molecular, Cellular, and Developmental Biology [L. W.], University of California, Santa Barbara, California 93106, and Bhupat and Jyoti Mehta School of Biosciences and Bioengineering, Indian Institute of Technology, Bombay, Mumbai, India 400076 [D. P.]
In studies on the antiproliferative actions of coumarin compounds, we discovered that dicoumarol (a coumarin anticoagulant; 3,3'-methylenebis[4-hydroxycoumarin]) inhibits the first cleavage of Strongylocentrotus purpuratus (sea urchin) embryos in a concentration-dependent manner with 50% inhibition occurring at a concentration of 10 µM. Because first cleavage in sea urchin embryos is highly selective for microtubule-targeted agents, we thought that the active compounds might inhibit cell division by interacting with tubulin or microtubules. We found that dicoumarol binds to bovine brain tubulin with a Kd of 22 µM and that 0.1 µM dicoumarol strongly stabilizes the growing and shortening dynamics at the plus ends of the microtubules in vitro. Dicoumarol reduces the rate and extent of shortening, it increases the percentage of time the microtubules spend in an attenuated (paused) state, and it reduces the overall dynamicity of the microtubules. The antimitotic effects of the widely used cancer chemotherapeutic agent Taxol (paclitaxel) are also mediated by suppressing microtubule dynamics. We demonstrate that exposure to combinations of Taxol and dicoumarol results in a synergistic inhibition of cell division of sea urchin embryos. The results suggest that the antiproliferative mechanism of action of dicoumarol and possibly related pharmacophores may be mediated by tubulin binding and the stabilization of spindle microtubule dynamics. Because of its low toxicity and simple chemical structure, there is potential interest to explore combinations of antimitotic coumarins with other chemotherapeutic agents to improve efficacy and lower toxicity.
This article has been cited by other articles:
![]() |
A. Alard, B. Fabre, R. Anesia, C. Marboeuf, P. Pierre, C. Susini, C. Bousquet, and S. Pyronnet NAD(P)H Quinone-Oxydoreductase 1 Protects Eukaryotic Translation Initiation Factor 4GI from Degradation by the Proteasome Mol. Cell. Biol., February 15, 2010; 30(4): 1097 - 1105. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. DeBolt, R. Gutierrez, D. W. Ehrhardt, C. V. Melo, L. Ross, S. R. Cutler, C. Somerville, and D. Bonetta Morlin, an inhibitor of cortical microtubule dynamics and cellulose synthase movement PNAS, April 3, 2007; 104(14): 5854 - 5859. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Du, D. H. Daniels, C. Asbury, S. Venkataraman, J. Liu, D. R. Spitz, L. W. Oberley, and J. J. Cullen Mitochondrial Production of Reactive Oxygen Species Mediate Dicumarol-induced Cytotoxicity in Cancer Cells J. Biol. Chem., December 8, 2006; 281(49): 37416 - 37426. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Styers, A. P. Kowalczyk, and V. Faundez Architecture of the vimentin cytoskeleton is modified by perturbation of the GTPase ARF1 J. Cell Sci., September 1, 2006; 119(17): 3643 - 3654. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Aneja, J. Zhou, S. N. Vangapandu, B. Zhou, R. Chandra, and H. C. Joshi Drug-resistant T-lymphoid tumors undergo apoptosis selectively in response to an antimicrotubule agent, EM011 Blood, March 15, 2006; 107(6): 2486 - 2492. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Panda, K. Rathinasamy, M. K. Santra, and L. Wilson From the Cover: Kinetic suppression of microtubule dynamic instability by griseofulvin: Implications for its possible use in the treatment of cancer PNAS, July 12, 2005; 102(28): 9878 - 9883. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Gapud, R. Bai, A. K. Ghosh, and E. Hamel Laulimalide and Paclitaxel: A Comparison of Their Effects on Tubulin Assembly and Their Synergistic Action When Present Simultaneously Mol. Pharmacol., July 1, 2004; 66(1): 113 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lewis, M. Ough, L. Li, M. M. Hinkhouse, J. M. Ritchie, D. R. Spitz, and J. J. Cullen Treatment of Pancreatic Cancer Cells with Dicumarol Induces Cytotoxicity and Oxidative Stress Clin. Cancer Res., July 1, 2004; 10(13): 4550 - 4558. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |